Programs

  • Program 1 [2020]

    BAA: EVAC AND FIVESENDOVASCULAR VARIABLE AORTIC CONTROL SYSTEM (EVAC): IMPROVED ENDOVASCULAR TECHNOLOGY IS NEEDED TO OPTIMIZE OUTCOMES OF WOUNDED WARFIGHTERS WITH NONCOMPRESSIBLE TORSO HEMORRHAGE. THIS PROJECT WILL DEVELOP A CLINICAL-GRADE EVAC SYSTEM TO IMPROVE OUTCOMES IN THESE PATIENTS. A NEXT-GENERATION "INTELLIGENT" ENDOVASCULAR DEVICE TO IMPROVE HEMORRHAGE CONTROL IN WOUNDED WARFIGHTERS WILL BE DEVELOPED. FIELD INTRAVENOUS EXPEDITIONARY SYSTEM (FIVES): THE USAF REQUIRES AN FDA APPROVED FIVES FOR AIR FORCE MEDIAL SERVICE USED IN DEPLOYED SCENARIOS, INCLUDING WARTIME OPERATIONS, DETERRENCE, HUMANITARIAN, AND CONTINGENCY OPERATIONS. THIS PROJECT WILL DEVELOP A SYSTEM TO GENERATE STERILE WATER FOR INJECTION (WIFI) TO CONSTITUTE MULTIPLE FORMULATIONS OF INTRAVENOUS (IV) SOLUTIONS CONSISTING OF RINGERS LACTATE, LYOPHILIZED HUMAN PLASMA, SALINE AND OTHER STERILE FLUIDS AND/OR BIOLOGICS AND MEDICATIONS UTILIZED IN THE EXPEDITIONARY MEDICAL SUPPORT SYSTEM SITES.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $2.5M

  • Program 2 [2020]

    EPACC: ENDOVASCULAR PERFUSION AUGMENTATION FOR CRITICAL CARE (EPACC) IS A NOVEL TECHNOLOGY THAT UTILIZES AUTOMATED MODULATION OF AN INTRAAORTIC BALLOON CATHETER TO AUGMENT BLOOD FLOW AND PRESSURE TO THE HEART, LUNGS AND BRAIN, WHILE STILL MAINTAINING ADEQUATE DOWNSTREAM AORTIC BLOOD FLOW, THUS MINIMIZING THE REQUIREMENTS FOR FLUID AND VASOPRESSOR SUPPORT.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $1M

  • Program 3 [2020]

    VENTRIGHT: QUALITY VENTILATION IS THE DELIVERY OF THE APPROPRIATE RATE, AMOUNT, AND TIMING OF BREATHS, TO AVOID ADDITIONAL INJURY. YET POINT OF INJURY CARE CREATES MULTIPLE COMPETING CARE RESPONSIBILITIES AND HIGH-QUALITY, CONSISTENT MANUAL VENTILATION IS EXTREMELY DIFFICULT. THE SCOPE OF THIS EFFORT IS TO DEVELOP TECHNOLOGY FOR REAL-TIME PHYSIOLOGIC MONITORING COMBINED WITH VENTILATION WAVEFORMS (FLOW AND PRESSURE) THAT CAN DIAGNOSE COMMON CAUSES OF TREATABLE RESPIRATORY FAILURE AND OPTIMIZE VENTILATION OF CRITICALLY ILL AND INJURED WARFIGHTERS.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $928.1K